Advanced search
Publication Cover
Postgraduate Medicine Volume 127, 2015 - Issue 4
Submit an article Journal homepage
994
Views
57
CrossRef citations to date
0
Altmetric
Clinical Feature Case Report

Persistence of mixed cryoglobulinemia despite cure of hepatitis C with new oral antiviral therapy including direct-acting antiviral sofosbuvir: A case series

Scott L. CornellaDepartment of Medicine, University of Virginia, Charlottesville, VA, USA
,
Jonathan G. StineDivision of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA, USA
,
Virginia KellyDivision of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA, USA
,
Stephen H. CaldwellDivision of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA, USA
&
Neeral L. ShahDivision of Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA, USACorrespondence[email protected]
Pages 413-417 | Received 04 Dec 2014, Accepted 17 Feb 2015, Published online: 07 Mar 2015

Citations (57)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Amany F. Mohamed, Amany M. Abo-Ouf & Mona A.A. Arafa. (2021) Histological and biochemical studies on effect of Sofosbuvir (Sovaldi) on adult male albino rat kidney. Ultrastructural Pathology 45:4-5, pages 286-296.
Read now
Muhammad Umair Khan, Mohamed Ibrahim Mahmoud & Adeel A. Butt. (2020) Hepatitis c virus and chronic kidney disease. Expert Review of Gastroenterology & Hepatology 14:7, pages 579-590.
Read now
Soledad Retamozo, Pilar Brito-Zerón, Luca Quartuccio, Salvatore De Vita & Manuel Ramos-Casals. (2017) Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection. Expert Review of Clinical Pharmacology 10:10, pages 1085-1101.
Read now
Fabrizio Fabrizi, Paul Martin, Patrice Cacoub, Piergiorgio Messa & Francesca M Donato. (2015) Treatment of hepatitis C-related kidney disease. Expert Opinion on Pharmacotherapy 16:12, pages 1815-1827.
Read now

Articles from other publishers (53)

M. Jadoul, A.A. Awan, M.C. Berenguer, A. Bruchfeld, F. Fabrizi, D.S. Goldberg, J. Jia, N. Kamar, R. Mohamed, M.G. Pessôa, S. Pol, M.E. Sise & P. Martin. (2022) KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney International 102:6, pages S129-S205.
Crossref
Walid Ahmed Ragab Abdelhamid, Ali Shendi, Mahmoud Zahran, Eman Abd Elbary & Sawsan Fadda. (2022) Hepatitis C-related membranoproliferative glomerulonephritis in the era of direct antiviral agents. Brazilian Journal of Nephrology 44:2, pages 291-295.
Crossref
Laura Gragnani, Serena Lorini, Silvia Marri, Caterina Vacchi, Francesco Madia, Monica Monti, Clodoveo Ferri & Anna Linda Zignego. (2022) Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life. Autoimmunity Reviews 21:1, pages 102923.
Crossref
Anna L. ZIGNEGO, Silvia MARRI & Laura GRAGNANI. (2021) Impact of direct acting antivirals on hepatitis C virus-related cryoglobulinemic syndrome. Minerva Gastroenterology 67:3.
Crossref
Abraham Cohen-Bucay, Jean M. Francis & Craig E. Gordon. (2021) Progress in hepatitis C virus management in chronic kidney disease. Current Opinion in Nephrology & Hypertension 30:5, pages 493-500.
Crossref
Ming-Ling Chang, Jing-Hong Hu, Wei-Ting Chen, Ming-Shyan Lin, Chia-Jung Kuo, Shiang-Chi Chen & Rong-Nan Chien. (2020) Interactive Impacts from Hepatitis C Virus Infection and Mixed Cryoglobulinemia on Complement Levels. Digestive Diseases and Sciences 66:7, pages 2407-2416.
Crossref
Raissa M Arruda, Andrea D Batista, Norma A Filgueira, Izolda F Moura, Luis H Sette & Edmundo P Lopes. (2021) Remission of long-term hepatic and renal disease induced by HCV after direct-acting antivirals therapy. Brazilian Journal of Nephrology 43:1, pages 117-120.
Crossref
Gigi Y. Liu, Olive Tang, Daniel J. Brotman, Edgar R. Miller, Alison R. Moliterno & Stephen P. Juraschek. (2020) Gamma gap thresholds and HIV, hepatitis C, and monoclonal gammopathy. PLOS ONE 15:1, pages e0224977.
Crossref
Evangelista Sagnelli, Caterina Sagnelli, Antonio Russo, Mariantonietta Pisaturo, Clarissa Camaioni, Roberta Astorri & Nicola Coppola. 2021. Advances in Microbiology, Infectious Diseases and Public Health. Advances in Microbiology, Infectious Diseases and Public Health 115 147 .
Tarek A. Elshazly, Amr M. Elrabat, Sahar A. M. Ali, Muhammed Diasty & Mohamed El-Desoky. (2020) Role of different direct-acting antiviral drugs on hepatitis C virus-associated mixed cryoglobulinemia in Egyptian patients. The Egyptian Journal of Internal Medicine 31:4, pages 458-464.
Crossref
Bogdan Obrișcă, Roxana Jurubiță, Bogdan Sorohan, Laura Iliescu, Cătălin Baston, Raluca Bobeică, Andreea Andronesi, Nicolae Leca & Gener Ismail. (2019) Clinical outcome of HCV-associated cryoglobulinemic glomerulonephritis following treatment with direct acting antiviral agents: a case-based review. Clinical Rheumatology 38:12, pages 3677-3687.
Crossref
Dario Roccatello, Roberta Fenoglio & Savino Sciascia. (2019) The dilemma of treating hepatitis C virus-associated cryoglobulinemia. Current Opinion in Rheumatology 31:5, pages 499-504.
Crossref
S. Yu Milovanova, L. V Kozlovskaya(Lysenko)L. Yu Milovanova, N. B Gordovskaya, T. M Ignatova, M. V Taranova & T. V Androsova. (2019) Hepatitis C virus - related cryoglobulinemic vasculitis with renal involvement current possibilities of diagnostic and treatment. Terapevticheskii arkhiv 91:6, pages 124-130.
Crossref
Diego Barbieri, Ana García-Prieto, Esther Torres, Eduardo Verde, Marian Goicoechea & José Luño. (2019) Mixed cryoglobulinaemia vasculitis after sustained hepatitis C virological response with direct-acting antivirals. Clinical Kidney Journal 12:3, pages 362-364.
Crossref
Eleni Koukoulioti & Thomas Berg. 2019. Evidence‐based Gastroenterology and Hepatology 4e. Evidence‐based Gastroenterology and Hepatology 4e 470 489 .
Andrea Angeletti, Chiara Cantarelli & Paolo Cravedi. (2019) HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents. Frontiers in Medicine 6.
Crossref
Franco Dammacco, Gianfranco Lauletta, Sabino Russi, Patrizia Leone, Marco Tucci, Carlo Manno, Salvatore Monaco, Sergio Ferrari, Angelo Vacca & Vito Racanelli. (2018) Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis. Clinical and Experimental Medicine 19:1, pages 1-21.
Crossref
Fabrizio Fabrizi & Piergiorgio Messa. 2019. Glomerulonephritis. Glomerulonephritis 483 498 .
Andreas M. Reimold. 2019. Infections and the Rheumatic Diseases. Infections and the Rheumatic Diseases 91 106 .
Joshua D. Long, Stephanie M. Rutledge & Meghan E. Sise. (2018) Autoimmune Kidney Diseases Associated with Chronic Viral Infections. Rheumatic Disease Clinics of North America 44:4, pages 675-698.
Crossref
. (2018) KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney International Supplements 8:3, pages 91-165.
Crossref
Mohamed Tharwat Hegazy, Walaa Ramadan Allam, Mohamed A. Hussein, Naguib Zoheir, Luca Quartuccio, Sherif F. El-Khamisy & Gaafar Ragab. (2018) Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs. EBioMedicine 35, pages 106-113.
Crossref
L. Gragnani, G. Cerretelli, S. Lorini, C. Steidl, A. Giovannelli, M. Monti, L. Petraccia, S. Sadalla, T. Urraro, P. Caini, A. Xheka, A. Simone, U. Arena, M. Matucci‐Cerinic, D. Vergani, G. Laffi & A. L. Zignego. (2018) Interferon‐free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis. Alimentary Pharmacology & Therapeutics 48:4, pages 440-450.
Crossref
Dominick Santoriello, Nanda K. Pullela, Kalpana A. Uday, Shawn Dhupar, Jai Radhakrishnan, Vivette D. D’Agati & Glen S Markowitz. (2018) Persistent Hepatitis C Virus−Associated Cryoglobulinemic Glomerulonephritis in Patients Successfully Treated With Direct-Acting Antiviral Therapy. Kidney International Reports 3:4, pages 985-990.
Crossref
Fabrizio Fabrizi, Alessio Aghemo, Pietro Lampertico, Mirella Fraquelli, Donata Cresseri, Gabriella Moroni, Patrizia Passerini, Francesca M Donato & Piergiorgio Messa. (2018) Immunosuppressive and antiviral treatment of hepatitis C virus–associated glomerular disease: A long-term follow-up. The International Journal of Artificial Organs 41:6, pages 306-318.
Crossref
Nuria Montero, Alexandre Favà, Eva Rodriguez, Clara Barrios, Josep M Cruzado, Julio Pascual & Maria Jose Soler. (2018) Treatment for hepatitis C virus-associated mixed cryoglobulinaemia. Cochrane Database of Systematic Reviews 2018:5.
Crossref
D. Salmon, M. U. Mondelli, M. Maticic & J. E. Arends. (2018) The benefits of hepatitis C virus cure: Every rose has thorns. Journal of Viral Hepatitis 25:4, pages 320-328.
Crossref
Stephanie M. Rutledge, Raymond T. Chung & Meghan E. Sise. (2018) Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis. Hemodialysis International 22:S1.
Crossref
Massimo Andreoni, Sergio Babudieri, Savino Bruno, Massimo Colombo, Anna L. Zignego, Vito Di Marco, Giovanni Di Perri, Carlo F. Perno, Massimo Puoti, Gloria Taliani, Erica Villa & Antonio Craxì. (2017) Current and future challenges in HCV: insights from an Italian experts panel. Infection 46:2, pages 147-163.
Crossref
Marina Artemova, Dzhamal Abdurakhmanov, Tatiana Krasnova & Nikolay Mukhin. (2018) Genetic and clinical data predict onset of cryoglobulinemia in HCV patients and cryoglobulins clearance. Digestive and Liver Disease 50:3, pages 318-320.
Crossref
Abhilash Koratala & Xu Zeng. (2018) Rituximab therapy for hepatitis C virus‐associated cryoglobulinemic membranoproliferative glomerulonephritis. Clinical Case Reports 6:2, pages 442-443.
Crossref
Patrice Cacoub, Mathieu Vautier, Anne Claire Desbois, Antoine Lafuma & David Saadoun. (2017) Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon‐based to direct‐acting antivirals era. Liver International 37:12, pages 1805-1813.
Crossref
L.E. Wiznia, M.E. Laird & A.G. FranksJrJr. (2017) Hepatitis C virus and its cutaneous manifestations: treatment in the direct‐acting antiviral era. Journal of the European Academy of Dermatology and Venereology 31:8, pages 1260-1270.
Crossref
Joel S Emery, Magdalena Kuczynski, Danie La, Saeed Almarzooqi, Matthew Kowgier, Hemant Shah, David Wong, Harry L A Janssen & Jordan J Feld. (2017) Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia. American Journal of Gastroenterology 112:8, pages 1298-1308.
Crossref
Elisabetta Degasperi, Alessio Aghemo & Massimo Colombo. (2017) Treatment of Extrahepatic Manifestations of Hepatitis C Virus. Clinics in Liver Disease 21:3, pages 631-643.
Crossref
David E. Kaplan. (2017) Persistence of exhaustion in cured hep C. Blood 130:1, pages 4-4.
Crossref
Dario Roccatello, Savino Sciascia, Daniela Rossi, Laura Solfietti, Roberta Fenoglio, Elisa Menegatti & Simone Baldovino. (2017) The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents. Oncotarget 8:25, pages 41764-41777.
Crossref
Anna Linda Zignego, Manuel Ramos-Casals, Clodoveo Ferri, David Saadoun, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, Anne Claire Desbois, Cloe Comarmond, Laura Gragnani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi & Patrice Cacoub. (2017) International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmunity Reviews 16:5, pages 523-541.
Crossref
Fumiaki Obata, Taichi Murakami, Junko Miyagi, Sayo Ueda, Taizo Inagaki, Masanori Minato, Hiroyuki Ono, Kenji Nishimura, Eriko Shibata, Masanori Tamaki, Sakiya Yoshimoto, Fumi Kishi, Seiji Kishi, Motokazu Matsuura, Kojiro Nagai, Hideharu Abe & Toshio Doi. (2016) A case of rapid amelioration of hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis treated by interferon-free directly acting antivirals for HCV in the absence of immunosuppressant. CEN Case Reports 6:1, pages 55-60.
Crossref
Marina Artemova, Dzhamal Abdurakhmanov, Tatiana Ignatova & Nikolay Mukhin. (2017) Persistent hepatitis C virus–associated cryoglobulinemic vasculitis following virus eradication after direct‐acting antiviral therapy. Hepatology 65:5, pages 1770-1771.
Crossref
Martín Bonacci, Sabela Lens, María-Carlota Londoño, Zoe Mariño, Maria C. Cid, Manuel Ramos-Casals, Jose María Sánchez-Tapias, Xavier Forns & José Hernández-Rodríguez. (2017) Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus–Associated Cryoglobulinemia Treated With Direct-Acting Antivirals. Clinical Gastroenterology and Hepatology 15:4, pages 575-583.e1.
Crossref
Fabrizio Fabrizi & Piergiorgio Messa. 2017. Glomerulonephritis. Glomerulonephritis 1 16 .
Douglas D. Richman, Richard J. Whitley & Frederick J. HaydenChristopher Koh, Qisheng Li & Jake Liang. 2016. Clinical Virology. Clinical Virology 1313 1345 .
Yuval A. Patel & Andrew J. Muir. (2016) Treatment of HCV in Renal Disease: Subtle Management Considerations in the Era of Direct-Acting Antivirals. Current Hepatology Reports 15:4, pages 285-290.
Crossref
Laura Gragnani, Marcella Visentini, Elisa Fognani, Teresa Urraro, Adriano De Santis, Luisa Petraccia, Marie Perez, Giorgia Ceccotti, Stefania Colantuono, Milica Mitrevski, Cristina Stasi, Martina Del Padre, Monica Monti, Elena Gianni, Alessandro Pulsoni, Massimo Fiorilli, Milvia Casato & Anna Linda Zignego. (2016) Prospective study of guideline‐tailored therapy with direct‐acting antivirals for hepatitis C virus‐associated mixed cryoglobulinemia. Hepatology 64:5, pages 1473-1482.
Crossref
Patrice Cacoub, Anne Claire Desbois, Corinne Isnard-Bagnis, Dario Rocatello & Clodoveo Ferri. (2016) Hepatitis C virus infection and chronic kidney disease: Time for reappraisal. Journal of Hepatology 65:1, pages S82-S94.
Crossref
Franco Dammacco, Vito Racanelli, Sabino Russi & Domenico Sansonno. (2016) The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review. Clinical and Experimental Medicine 16:3, pages 233-242.
Crossref
Vincent Soriano, Pablo Labarga, José V Fernandez-Montero, Carmen de Mendoza, Isabella Esposito, Laura Benítez-Gutiérrez & Pablo Barreiro. (2016) Hepatitis C Cure with Antiviral Therapy – Benefits beyond the Liver. Antiviral Therapy 21:1, pages 1-8.
Crossref
Carlo Palazzi. (2016) Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis. World Journal of Gastroenterology 22:4, pages 1405.
Crossref
. 2016. Diagnostic Pathology: Kidney Diseases. Diagnostic Pathology: Kidney Diseases 174 179 .
Mihály Makara, Mihály Sulyok, Ottó Csacsovszki, Zita Sulyok & István Vályi-Nagy. (2015) Successful treatment of HCV-associated cryoglobulinemia with ombitasvir/paritaprevir/ritonavir, dasabuvir and ribavirin: A case report. Journal of Clinical Virology 72, pages 66-68.
Crossref
Dimitrios Vassilopoulos & Leonard H. Calabrese. (2015) HCV Treatments and Their Integration Into Rheumatology. Current Rheumatology Reports 17:8.
Crossref
Simone Garcovich. (2015) Cutaneous manifestations of hepatitis C in the era of new antiviral agents. World Journal of Hepatology 7:27, pages 2740.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.